LPA-1 receptor antagonists (InterMune)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLPA-1 receptor antagonists (InterMune)
Drug Alias NameLPA-1 receptor modulators (InterMune)ITMN-10534
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntermune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntermune Inc
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A